|
Key aims include shifting to a preventative service as opposed to a sick care service, with a focus on driving this with technology.
|
 |
|
The acquisition will bring the Nasdaq-listed Theratechnologies back under private ownership.
|
|
|
The BV500 programme is based on BioVersys’ Ansamycin Chemistry platform.
|
|
|
Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.
|
|
|
Ligand will receive a 13% royalty on global net sales of Zelsuvmi.
|
|
|
Joincare gains exclusive rights to research, develop and commercialise BRII-693 within the Greater China region.
|
|
